Health coaching boosts lifestyle in breast cancer patients, small study suggests
NCT ID NCT05873296
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 12-week health education program (including group meetings and social media tips) could improve lifestyle habits, physical activity, and emotional well-being in women being treated for breast cancer. Twenty-eight women took part. The goal was to see if simple, low-cost education could help them make healthier choices and feel better during treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- health education program (face-to-face meetings and social network information)
- What this could lead to
- If effective, this approach could offer a low-cost way to help women with breast cancer adopt healthier habits and improve quality of life during treatment.
- What could go wrong
- This is a very small completed study (28 women) with no blinding or placebo control, so results may not be reliable or apply to all patients. The intervention is behavioral, not a drug, so any benefits are likely modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Jul 2023
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women 18 years or older; * Diagnosed with breast cancer; * Ongoing breast cancer treatment (chemotherapy, radiotherapy and/or hormone therapy); * Have daily access to a smartphone. Exclusion Criteria: * Women having another type of cancer; * Perform physical training for three months before the intervention; * Has medical contraindication to perform any type of physical activity; * Have filled in yes on the PAR-Q and medical contraindication; * Without cognitive conditions to use a smartphone or answer questionnaires; * Illiterate women.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Andréa Dias Reis
São Luís, Maranhão, 65058185, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment
- Can a newer drug ease the bone pain of chemotherapy support?